Diffuse Glaucomatous Structural and Functional Damage in the Hemifield Without Significant Pattern Loss
Grewal et al.
Arch Ophthalmol 2009;127:1442-1448.
ABSTRACT
| FULL TEXT
Optic Disc and Visual Field Changes after Trabeculectomy
Kotecha et al.
IOVS 2009;50:4693-4699.
ABSTRACT
| FULL TEXT
Prediction of Functional Loss in Glaucoma From Progressive Optic Disc Damage
Medeiros et al.
Arch Ophthalmol 2009;127:1250-1256.
ABSTRACT
| FULL TEXT
Progressive Optic Disc Change: Implications for Clinical Practice and Trial Design
Chauhan
Arch Ophthalmol 2009;127:1382-1383.
FULL TEXT
Transplanted Oligodendrocyte Precursor Cells Reduce Neurodegeneration in a Model of Glaucoma
Bull et al.
IOVS 2009;50:4244-4253.
ABSTRACT
| FULL TEXT
Reliability and Sensitivity of the TonoLab Rebound Tonometer in Awake Brown Norway Rats
Morrison et al.
IOVS 2009;50:2802-2808.
ABSTRACT
| FULL TEXT
An Objective Evaluation of Eyedrop Instillation in Patients With Glaucoma
Stone et al.
Arch Ophthalmol 2009;127:732-736.
ABSTRACT
| FULL TEXT
Interpretation of the glaucoma "landmark studies"
Wishart
Br J Ophthalmol 2009;93:561-562.
FULL TEXT
Genetic Risk for Primary Open-Angle Glaucoma Determined by LMX1B Haplotypes
Park et al.
IOVS 2009;50:1522-1530.
ABSTRACT
| FULL TEXT
Detection of Progressive Retinal Nerve Fiber Layer Loss in Glaucoma Using Scanning Laser Polarimetry with Variable Corneal Compensation
Medeiros et al.
IOVS 2009;50:1675-1681.
ABSTRACT
| FULL TEXT
Primary Open-Angle Glaucoma
Kwon et al.
NEJM 2009;360:1113-1124.
FULL TEXT
Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials
Honrubia et al.
Br J Ophthalmol 2009;93:316-321.
ABSTRACT
| FULL TEXT
Ocular Hypertension Treatment Study
Higginbotham
Arch Ophthalmol 2009;127:213-215.
FULL TEXT
Preventing Glaucoma in a High-Risk Population: Impact and Observations of the Ocular Hypertension Treatment Study
Rhee
Arch Ophthalmol 2009;127:216-218.
FULL TEXT
Intracranial Pressure in Primary Open Angle Glaucoma, Normal Tension Glaucoma, and Ocular Hypertension: A Case-Control Study
Berdahl et al.
IOVS 2008;49:5412-5418.
ABSTRACT
| FULL TEXT
Effects of the Timolol-Dorzolamide Fixed Combination and Latanoprost on Circadian Diastolic Ocular Perfusion Pressure in Glaucoma
Quaranta et al.
IOVS 2008;49:4226-4231.
ABSTRACT
| FULL TEXT
Predictors of and Barriers Associated With Poor Follow-up in Patients With Glaucoma in South India
Lee et al.
Arch Ophthalmol 2008;126:1448-1454.
ABSTRACT
| FULL TEXT
Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4
Williams et al.
Br J Ophthalmol 2008;92:1387-1392.
ABSTRACT
| FULL TEXT
A Viscoelastic Biomechanical Model of the Cornea Describing the Effect of Viscosity and Elasticity on Hysteresis
Glass et al.
IOVS 2008;49:3919-3926.
ABSTRACT
| FULL TEXT
Canadian Glaucoma Study: 2. Risk Factors for the Progression of Open-angle Glaucoma
Chauhan et al.
Arch Ophthalmol 2008;126:1030-1036.
ABSTRACT
| FULL TEXT
Finding Risks for Glaucoma
Brandt
Arch Ophthalmol 2008;126:1138-1139.
FULL TEXT
Heritability of intraocular pressure: a classical twin study
Carbonaro et al.
Br J Ophthalmol 2008;92:1125-1128.
ABSTRACT
| FULL TEXT
Mapping Standard Automated Perimetry to the Peripapillary Retinal Nerve Fiber Layer in Glaucoma
Ferreras et al.
IOVS 2008;49:3018-3025.
ABSTRACT
| FULL TEXT
Glaucoma and Fitness to Drive: Using Binocular Visual Fields to Predict a Milestone to Blindness
Owen et al.
IOVS 2008;49:2449-2455.
ABSTRACT
| FULL TEXT
An unexpectedly low Stratus optical coherence tomography false-positive rate in the non-nasal quadrants of Asian eyes: indirect evidence of differing retinal nerve fibre layer thickness profiles according to ethnicity
Kim et al.
Br J Ophthalmol 2008;92:735-739.
ABSTRACT
| FULL TEXT
Health literacy and vision-related quality of life
Muir et al.
Br J Ophthalmol 2008;92:779-782.
ABSTRACT
| FULL TEXT
Transgenic Mice Expressing the Tyr437His Mutant of Human Myocilin Protein Develop Glaucoma
Zhou et al.
IOVS 2008;49:1932-1939.
ABSTRACT
| FULL TEXT
Bayesian Machine Learning Classifiers for Combining Structural and Functional Measurements to Classify Healthy and Glaucomatous Eyes
Bowd et al.
IOVS 2008;49:945-953.
ABSTRACT
| FULL TEXT
Open-angle Glaucoma and Mortality: The Barbados Eye Studies
Wu et al.
Arch Ophthalmol 2008;126:365-370.
ABSTRACT
| FULL TEXT
Tissue Transglutaminase Expression and Activity in Normal and Glaucomatous Human Trabecular Meshwork Cells and Tissues
Tovar-Vidales et al.
IOVS 2008;49:622-628.
ABSTRACT
| FULL TEXT
Misclassification: Who Really Lives in This Neighborhood?
Sommer
Arch Ophthalmol 2008;126:265-266.
FULL TEXT
Is a History of Diabetes Mellitus Protective Against Developing Primary Open-angle Glaucoma?
Gordon et al.
Arch Ophthalmol 2008;126:280-281.
FULL TEXT
Estimating the Rate of Progressive Visual Field Damage in Those with Open-Angle Glaucoma, from Cross-Sectional Data
Broman et al.
IOVS 2008;49:66-76.
ABSTRACT
| FULL TEXT
Optimizing Therapy for Newly Diagnosed Open-angle Glaucoma: Lessons Learned From the Collaborative Initial Glaucoma Treatment Study
Pasquale
Arch Ophthalmol 2008;126:125-127.
FULL TEXT
Using Pharmacy Claims Data to Study Adherence to Glaucoma Medications: Methodology and Findings of the Glaucoma Adherence and Persistency Study (GAPS)
Friedman et al.
IOVS 2007;48:5052-5057.
ABSTRACT
| FULL TEXT
What's in a name? Medication terms: what they mean and when to use them
Wride et al.
Br J Ophthalmol 2007;91:1422-1424.
FULL TEXT
Novel pressure-to-cornea index in glaucoma
Iliev et al.
Br J Ophthalmol 2007;91:1364-1368.
ABSTRACT
| FULL TEXT
Expression of ephrinB1 and its receptor in glaucomatous optic neuropathy
Schmidt et al.
Br J Ophthalmol 2007;91:1219-1224.
ABSTRACT
| FULL TEXT
Intraocular Pressure Fluctuation: An Independent Risk Factor for Glaucoma?
Caprioli
Arch Ophthalmol 2007;125:1124-1125.
FULL TEXT
Presence of an Established Calcification Marker in Trabecular Meshwork Tissue of Glaucoma Donors
Xue et al.
IOVS 2007;48:3184-3194.
ABSTRACT
| FULL TEXT
The 100 Most Frequently Cited Articles in Ophthalmology Journals
Ohba et al.
Arch Ophthalmol 2007;125:952-960.
ABSTRACT
| FULL TEXT
Comparison of Initial Intraocular Pressure Response With Topical beta-Adrenergic Antagonists and Prostaglandin Analogues in African American and White Individuals in the Ocular Hypertension Treatment Study
Mansberger et al.
Arch Ophthalmol 2007;125:454-459.
ABSTRACT
| FULL TEXT
Effects of TGF-{beta}2, BMP-4, and Gremlin in the Trabecular Meshwork: Implications for Glaucoma
Wordinger et al.
IOVS 2007;48:1191-1200.
ABSTRACT
| FULL TEXT
Genes Involved in the Pathogenesis of Primary Open-Angle Glaucoma: In Search of the Holy Grail
Pasquale
JAMA 2007;297:306-307.
FULL TEXT
Blood flow in glaucoma
Orgul
Br J Ophthalmol 2007;91:3-5.
FULL TEXT
Comparison of the Stability, Efficacy, and Adverse Effect Profile of the Innovator 0.005% Latanoprost Ophthalmic Solution and a Novel Cyclodextrin-containing Formulation
Gonzalez et al.
J Clin Pharmacol 2007;47:121-126.
ABSTRACT
| FULL TEXT
Expression of Mutated Mouse Myocilin Induces Open-Angle Glaucoma in Transgenic Mice.
Senatorov et al.
J. Neurosci. 2006;26:11903-11914.
ABSTRACT
| FULL TEXT
Effect of beta radiation on success of glaucoma drainage surgery in South Africa: randomised controlled trial
Kirwan et al.
BMJ 2006;333:942.
ABSTRACT
| FULL TEXT
Concordance of Aqueous Humor Flow in the Morning and at Night in Normal Humans
Radenbaugh et al.
IOVS 2006;47:4860-4864.
ABSTRACT
| FULL TEXT
The Rate of Functional Recovery from Acute IOP Elevation
He et al.
IOVS 2006;47:4872-4880.
ABSTRACT
| FULL TEXT
Pattern ERG as an Early Glaucoma Indicator in Ocular Hypertension: A Long-Term, Prospective Study
Bach et al.
IOVS 2006;47:4881-4887.
ABSTRACT
| FULL TEXT
Ocular Response Analyzer versus Goldmann Applanation Tonometry for Intraocular Pressure Measurements.
Martinez-de-la-Casa et al.
IOVS 2006;47:4410-4414.
ABSTRACT
| FULL TEXT
Asymmetries and visual field summaries as predictors of glaucoma in the ocular hypertension treatment study.
Levine et al.
IOVS 2006;47:3896-3903.
ABSTRACT
| FULL TEXT
Twice-Daily 0.2% Brimonidine-0.5% Timolol Fixed-Combination Therapy vs Monotherapy With Timolol or Brimonidine in Patients With Glaucoma or Ocular Hypertension: A 12-Month Randomized Trial.
Sherwood et al.
Arch Ophthalmol 2006;124:1230-1238.
ABSTRACT
| FULL TEXT
Genomewide scan and fine mapping of quantitative trait Loci for intraocular pressure on 5q and 14q in west africans.
Rotimi et al.
IOVS 2006;47:3262-3267.
ABSTRACT
| FULL TEXT
Structure-function relationships using confocal scanning laser ophthalmoscopy, optical coherence tomography, and scanning laser polarimetry.
Bowd et al.
IOVS 2006;47:2889-2895.
ABSTRACT
| FULL TEXT
Effects of Topical Hypotensive Drugs on Circadian IOP, Blood Pressure, and Calculated Diastolic Ocular Perfusion Pressure in Patients with Glaucoma.
Quaranta et al.
IOVS 2006;47:2917-2923.
ABSTRACT
| FULL TEXT
Visual field defects and retinal ganglion cell losses in patients with glaucoma.
Harwerth and Quigley
Arch Ophthalmol 2006;124:853-859.
ABSTRACT
| FULL TEXT
Comparison of a non-preserved 0.1% T-Gel eye gel (single dose unit) with a preserved 0.1% T-Gel eye gel (multidose) in ocular hypertension and glaucomatous patients
Easty et al.
Br J Ophthalmol 2006;90:574-578.
ABSTRACT
| FULL TEXT
Matrix GLA Protein Function in Human Trabecular Meshwork Cells: Inhibition of BMP2-Induced Calcification Process.
Xue et al.
IOVS 2006;47:997-1007.
ABSTRACT
| FULL TEXT
Detection of psychophysical and structural injury in eyes with glaucomatous optic neuropathy and normal standard automated perimetry.
Bagga et al.
Arch Ophthalmol 2006;124:169-176.
ABSTRACT
| FULL TEXT
The rising cost of glaucoma drugs
Azuara-Blanco and Burr
Br J Ophthalmol 2006;90:130-131.
FULL TEXT
The rising cost of glaucoma drugs in Ireland 1996-2003
Knox et al.
Br J Ophthalmol 2006;90:162-165.
ABSTRACT
| FULL TEXT
A Multicenter, Retrospective Pilot Study of Resource Use and Costs Associated With Severity of Disease in Glaucoma
Lee et al.
Arch Ophthalmol 2006;124:12-19.
ABSTRACT
| FULL TEXT
Factors affecting the test-retest variability of Heidelberg retina tomograph and Heidelberg retina tomograph II measurements
Strouthidis et al.
Br J Ophthalmol 2005;89:1427-1432.
ABSTRACT
| FULL TEXT
Unsupervised Machine Learning with Independent Component Analysis to Identify Areas of Progression in Glaucomatous Visual Fields
Sample et al.
IOVS 2005;46:3684-3692.
ABSTRACT
| FULL TEXT
Validation of a Predictive Model to Estimate the Risk of Conversion From Ocular Hypertension to Glaucoma
Medeiros et al.
Arch Ophthalmol 2005;123:1351-1360.
ABSTRACT
| FULL TEXT
Screening for glaucoma
Harris
BMJ 2005;331:E376-E377.
FULL TEXT
Baseline Topographic Optic Disc Measurements Are Associated With the Development of Primary Open-Angle Glaucoma: The Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study
Zangwill et al.
Arch Ophthalmol 2005;123:1188-1197.
ABSTRACT
| FULL TEXT
Normal Visual Field Test Results Following Glaucomatous Visual Field End Points in the Ocular Hypertension Treatment Study
Keltner et al.
Arch Ophthalmol 2005;123:1201-1206.
ABSTRACT
| FULL TEXT
Mechanistic Insights into Glaucoma Provided by Experimental Genetics The Cogan Lecture
John
IOVS 2005;46:2650-2661.
FULL TEXT
Hypophosphorylation of Aqueous Humor sCD44 and Primary Open-Angle Glaucoma
Knepper et al.
IOVS 2005;46:2829-2837.
ABSTRACT
| FULL TEXT
Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials
Maier et al.
BMJ 2005;331:134.
ABSTRACT
| FULL TEXT
Reproducibility of Retinal Nerve Fiber Thickness Measurements Using the Stratus OCT in Normal and Glaucomatous Eyes
Budenz et al.
IOVS 2005;46:2440-2443.
ABSTRACT
| FULL TEXT
Twenty-four-Hour Control With Latanoprost-Timolol-Fixed Combination Therapy vs Latanoprost Therapy
Konstas et al.
Arch Ophthalmol 2005;123:898-902.
ABSTRACT
| FULL TEXT
Incorporating the Results of the Ocular Hypertension Treatment Study Into Clinical Practice
Kass et al.
Arch Ophthalmol 2005;123:1021-1022.
FULL TEXT
Intraocular pressure in the Middle East
Hennis
Br J Ophthalmol 2005;89:647-648.
FULL TEXT
Glaucoma and its treatment: A review
Lee and Higginbotham
Am J Health Syst Pharm 2005;62:691-699.
ABSTRACT
| FULL TEXT
Optical Coherence Tomography Longitudinal Evaluation of Retinal Nerve Fiber Layer Thickness in Glaucoma
Wollstein et al.
Arch Ophthalmol 2005;123:464-470.
ABSTRACT
| FULL TEXT
Long term effect on IOP of a stainless steel glaucoma drainage implant (Ex-PRESS) in combined surgery with phacoemulsification
Traverso et al.
Br J Ophthalmol 2005;89:425-429.
ABSTRACT
| FULL TEXT
Screening for Primary Open-Angle Glaucoma in the Primary Care Setting: An Update for the US Preventive Services Task Force
Fleming et al.
Ann Fam Med 2005;3:167-170.
ABSTRACT
| FULL TEXT
Plasminogen Activator Inhibitor-1 in the Aqueous Humor of Patients With and Without Glaucoma
Dan et al.
Arch Ophthalmol 2005;123:220-224.
ABSTRACT
| FULL TEXT
Neural Losses Correlated with Visual Losses in Clinical Perimetry
Harwerth et al.
IOVS 2004;45:3152-3160.
ABSTRACT
| FULL TEXT
Ocular Hypertension Treatment Study
Yablonski
Arch Ophthalmol 2004;122:1088-1089.
FULL TEXT
Ocular Hypertension Treatment Study--Reply
Kass and Gordon
Arch Ophthalmol 2004;122:1089-1089.
FULL TEXT
A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe
Garcia-Sanchez et al.
Br J Ophthalmol 2004;88:877-883.
ABSTRACT
| FULL TEXT
The Ocular Hypertension Treatment Study: Topical Medication Delays or Prevents Primary Open-angle Glaucoma in African American Individuals
Higginbotham et al.
Arch Ophthalmol 2004;122:813-820.
ABSTRACT
| FULL TEXT
Statins and Other Cholesterol-Lowering Medications and the Presence of Glaucoma
McGwin et al.
Arch Ophthalmol 2004;122:822-826.
ABSTRACT
| FULL TEXT
Comparison of the GDx VCC Scanning Laser Polarimeter, HRT II Confocal Scanning Laser Ophthalmoscope, and Stratus OCT Optical Coherence Tomograph for the Detection of Glaucoma
Medeiros et al.
Arch Ophthalmol 2004;122:827-837.
ABSTRACT
| FULL TEXT
Race and the Risk of Glaucoma
Miller
Arch Ophthalmol 2004;122:909-910.
FULL TEXT
Dietary fat consumption and primary open-angle glaucoma
Kang et al.
Am. J. Clin. Nutr. 2004;79:755-764.
ABSTRACT
| FULL TEXT
DNA microarray analysis of gene expression in human optic nerve head astrocytes in response to hydrostatic pressure
Yang et al.
Physiol. Genomics 2004;17:157-169.
ABSTRACT
| FULL TEXT
Prevalence of Open-Angle Glaucoma Among Adults in the United States
The Eye Diseases Prevalence Research Group
Arch Ophthalmol 2004;122:532-538.
ABSTRACT
| FULL TEXT
The Ocular Hypertension Treatment Study: Intraocular Pressure Lowering Prevents the Development of Glaucoma, but Does That Mean We Should Treat Before the Onset of Disease?
Robin et al.
Arch Ophthalmol 2004;122:376-378.
FULL TEXT
We Should Treat Fewer Patients With Elevated Intraocular Pressure Now That We Know the Results of the Ocular Hypertension Treatment Study
Jampel
Arch Ophthalmol 2004;122:378-379.
FULL TEXT
Intraobserver and interobserver reproducibility in the evaluation of ultrasonic pachymetry measurements of central corneal thickness
Miglior et al.
Br J Ophthalmol 2004;88:174-177.
ABSTRACT
| FULL TEXT
Do selective topical {beta} antagonists for glaucoma have respiratory side effects?
Kirwan et al.
Br J Ophthalmol 2004;88:196-198.
ABSTRACT
| FULL TEXT
Heritability of Risk Factors for Primary Open-Angle Glaucoma: The Beaver Dam Eye Study
Klein et al.
IOVS 2004;45:59-62.
ABSTRACT
| FULL TEXT
Glaucomatous Optic Neuropathy: When Glia Misbehave
Neufeld and Liu
Neuroscientist 2003;9:485-495.
ABSTRACT
Important Causes of Visual Impairment in the World Today
Congdon et al.
JAMA 2003;290:2057-2060.
FULL TEXT